Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

236.72
+5.552.40%
Pre-market: 236.720.00000.00%04:00 EDT
Volume:3K
Turnover:756.09K
Market Cap:474.98M
PE:- -
High:236.72
Open:236.01
Low:235.52
Close:231.17
52wk High:244.35
52wk Low:160.91
Shares:2.01M
Float Shares:2.01M
Volume Ratio:0.74
T/O Rate:0.16%
Dividend:0.95
Dividend Rate:0.40%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

TIPRANKS
·
8 hours ago

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

TIPRANKS
·
9 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
11 hours ago

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
11 hours ago

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

TIPRANKS
·
15 hours ago

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

TIPRANKS
·
Yesterday

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Dow Jones
·
Yesterday

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Reuters
·
Yesterday

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS
·
Sep 16

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
Sep 16

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Dow Jones
·
Sep 16

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Reuters
·
Sep 16

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Reuters
·
Sep 16

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
Sep 16

Revolution Medicines gets orphan designation for pancreatic cancer treatment

TIPRANKS
·
Sep 16

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live
·
Sep 15

Gilead announces agreement with PAHO for lenacapavir access

TIPRANKS
·
Sep 15

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS
·
Sep 15

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS
·
Sep 15